Search research articles
Contact Us
Filters
Showing results (231-240 of 236) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 236 results.
Clinical and Vaccine Immunology : CVI
|
May 1, 2015
Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors
Bryan E Hart, Rose Asrican, So-Yon Lim, et al.
Journal of Crohn'S & Colitis
|
April 17, 2025
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)
Jean-Frederic Colombel, William J Sandborn, Stefan Schreiber, et al.
Gastroenterology
|
May 24, 2024
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
Stephen B Hanauer, Bruce E Sands, Stefan Schreiber, et al.
Plos One
|
September 26, 2014
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells
Manjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, et al.
Frontiers in Immunology
|
June 24, 2025
Discovery and development of a safe and efficient COVID-19 mRNA vaccine, STP2104, using a novel capping library screening method
Kanghyun Choi, Joo-Young Lee, Uk-Il Kim, et al.
Autophagy
|
January 23, 2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J Klionsky, Kotb Abdelmohsen, Akihisa Abe, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 236) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 236 results.
Clinical and Vaccine Immunology : CVI
|
May 1, 2015
Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors
Bryan E Hart, Rose Asrican, So-Yon Lim, et al.
Journal of Crohn'S & Colitis
|
April 17, 2025
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)
Jean-Frederic Colombel, William J Sandborn, Stefan Schreiber, et al.
Gastroenterology
|
May 24, 2024
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
Stephen B Hanauer, Bruce E Sands, Stefan Schreiber, et al.
Plos One
|
September 26, 2014
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells
Manjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, et al.
Frontiers in Immunology
|
June 24, 2025
Discovery and development of a safe and efficient COVID-19 mRNA vaccine, STP2104, using a novel capping library screening method
Kanghyun Choi, Joo-Young Lee, Uk-Il Kim, et al.
Autophagy
|
January 23, 2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J Klionsky, Kotb Abdelmohsen, Akihisa Abe, et al.
Page
of 24